{
    "General": {
        "Code": "APGE",
        "Type": "Common Stock",
        "Name": "Apogee Therapeutics Inc. Common Stock",
        "Exchange": "NASDAQ",
        "CurrencyCode": "USD",
        "CurrencyName": "US Dollar",
        "CurrencySymbol": "$",
        "CountryName": "USA",
        "CountryISO": "US",
        "OpenFigi": "BBG01H51WYQ5",
        "ISIN": null,
        "LEI": null,
        "PrimaryTicker": null,
        "CUSIP": null,
        "CIK": "1974640",
        "EmployerIdNumber": null,
        "FiscalYearEnd": null,
        "IPODate": "2023-07-14",
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "HomeCategory": null,
        "IsDelisted": false,
        "Description": "Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 25,
        "UpdatedAt": "2023-08-18"
    },
    "Highlights": {
        "MarketCapitalization": null,
        "MarketCapitalizationMln": null,
        "EBITDA": null,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": null,
        "BookValue": null,
        "DividendShare": null,
        "DividendYield": null,
        "EarningsShare": null,
        "EPSEstimateCurrentYear": 0,
        "EPSEstimateNextYear": 0,
        "EPSEstimateNextQuarter": null,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": null,
        "ProfitMargin": 0,
        "OperatingMarginTTM": 0,
        "ReturnOnAssetsTTM": 0,
        "ReturnOnEquityTTM": 0,
        "RevenueTTM": 0,
        "RevenuePerShareTTM": 0,
        "QuarterlyRevenueGrowthYOY": 0,
        "GrossProfitTTM": 0,
        "DilutedEpsTTM": 0,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": 0,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 0,
        "SharesFloat": 0,
        "PercentInsiders": 0,
        "PercentInstitutions": 0,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": null,
        "52WeekHigh": 25.54,
        "52WeekLow": 17,
        "50DayMA": 0,
        "200DayMA": 0,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": null,
        "ExDividendDate": null,
        "LastSplitFactor": null,
        "LastSplitDate": null,
        "NumberDividendsByYear": {}
    },
    "AnalystRatings": {
        "Rating": null,
        "TargetPrice": null,
        "StrongBuy": null,
        "Buy": null,
        "Hold": null,
        "Sell": null,
        "StrongSell": null
    },
    "Holders": {
        "Institutions": {},
        "Funds": {}
    },
    "InsiderTransactions": {
        "0": {
            "date": "2023-07-13",
            "ownerCik": null,
            "ownerName": "Nimish P Shah",
            "transactionDate": "2023-07-13",
            "transactionCode": "P",
            "transactionAmount": 1750000,
            "transactionPrice": 17,
            "transactionAcquiredDisposed": "A",
            "postTransactionAmount": 1750000,
            "secLink": "http://www.sec.gov/Archives/edgar/data/1663607/000110465923081729/xslF345X05/tm2321456-6_4seq1.xml"
        }
    },
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {
            "2023-06-30": {
                "reportDate": "2023-07-17",
                "date": "2023-06-30",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": -3.78,
                "epsEstimate": -1.7,
                "epsDifference": -2.08,
                "surprisePercent": -122.3529
            },
            "2023-03-31": {
                "reportDate": "2023-05-31",
                "date": "2023-03-31",
                "beforeAfterMarket": null,
                "currency": null,
                "epsActual": -2.38,
                "epsEstimate": 0,
                "epsDifference": -2.38,
                "surprisePercent": null
            }
        },
        "Trend": {},
        "Annual": {
            "2023-06-30": {
                "date": "2023-06-30",
                "epsActual": -6.16
            }
        }
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}